Navigation mit Access Keys

Search


T3 Pharma qualifies for BaseLaunch funding program

The BaseLaunch program was launched in 2017 as an initiative of BaselArea.swiss, the office for business promotion for Northwestern Switzerland, with the aim of strengthening the start-up scene in the Basel region and…


Michael Hall receives the Frontiers of Knowledge Award

Today, the BBVA Foundation announced that Prof. Michael Hall from the Biozentrum of the University of Basel and Prof. David Sabatini from the MIT, USA, have been awarded the Frontiers of Knowledge Award in the category…


ERC Starting Grant for Physicist David Brückner

With its Starting Grant, the ERC supports outstanding young researchers who lay the foundation for an independent research program with their innovative projects. One of this year’s awardees is physicist Prof. David…


German pharma company acquires Biozentrum start-up for 450 million Swiss francs

T3 Pharmaceuticals (“T3 Pharma”) was founded in 2015 as a spin-off of the Biozentrum of the University of Basel. The company focuses on bacterial therapies for the treatment of solid tumors. The Basel-based biotech company’s…


Lethal combination: Drug cocktail turns off the “juice” to cancer cells

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the treatment of diabetes is too low to inhibit cancer growth. The…


New discovery reveals how diatoms capture CO2 so effectively

Diatoms are too small to see with the naked eye, yet they are one of the most productive algae species in the ocean and play an important role in the global carbon cycle. Using photosynthesis, they absorb large amounts of…


Therapy for muscular dystrophy: A new start-up at the Biozentrum

Congenital muscular dystrophy is a rare hereditary disease which cannot be cured. The more than 30 known forms of this neuromuscular disease differ in the type of genetic defect and in the severity of disease progression.…


Fiona Doetsch receives the 2026 Louis-Jeantet Prize for Medicine

Neurobiologist and stem cell biologist Prof. Fiona Doetsch has been awarded the 2026 Louis-Jeantet Prize for Medicine. She receives the prize for her pioneering work uncovering the identity and functions of neural stem cells…


Sleep-wake rhythm: Fish change our understanding of sleep regulation

Until recently, it was assumed that vertebrates share similar mechanisms controlling sleep behavior. That's why researchers have been using fish in the past 20 years as a model organism to study sleep and its regulation. Now…


New glial cells discovered in the brain: Implications for brain repair

The brain is malleable well into adulthood. Brain plasticity is not only due to the formation of new nerve connections. Stem cells present in the adult brain also generate new nerve cells. For more than a hundred years,…